University of Melbourne, Australia


The pjur lubricant was distributed as part of two chlamydia prevalence surveys that took place within the Australian Chlamydia Control Effectiveness Pilot (ACCEPt).

ACCEPt is a randomised controlled trial of chlamydia testing intervention in general practice clinics in 54 rural towns throughout Australia. A baseline chlamydia prevalence survey was conducted from 2010–2012.

The aim of the survey is to estimate chlamydia prevalence among young people (aged 16–29 years) attending general practice clinics and determine whether the ACCEPt intervention had any impact on chlamydia prevalence. Participants are tested for chlamydia and complete a questionnaire. As thanks for their participation, we provide each participant with sexual health information, condoms and lubricant. Over 4000 men and women participated in the baseline survey and we expect similar numbers for the follow-up survey. All the donated lubricant from pjur has been distributed to participants. Results from the trial are reported in medical literature.

pjur is listed as a supporting organisation on the ACCEPt website. http://www.accept.org.au/supporting.aspx. pjur products have been distributed to participants in the Australian Chlamydia Control Effectiveness Pilot.


Questions?
Contact us!

Annika Junk
Customer Service Coordinator

pjur group Luxembourg S.A.
87, esplanade de la Moselle
6637 Wasserbillig
Luxembourg

phone: +352 74 8989 44
e-mail: annika@pjurmed.com